Immunomedics

Developer of antibodies and antibody-drug conjugates for the treatment of cancer and autoimmune diseases

placeMorris Plains, New Jersey, United States calendar_todayFounded 1982 groups358 employees language immunomedics.com

Registered entities

Innovation

242 patent families (185 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Operations & transport; filing pace slowing. Cited 62,410 times.

YearFilings
201563
201667
201763
201847
201936
202022
202125
202212
202314
202412
20256
20263

Investor mix

8 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital450%
Private equity225%
Other / undisclosed225%
Coming soon